Orthopedic Devices - Mongolia

  • Mongolia
  • The projected revenue in the Orthopedic Devices market market in Mongolia is estimated to reach US$6.07m in 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 3.47%, leading to a market volume of US$7.20m by 2029.
  • In terms of global comparison, the United States is anticipated to generate the highest revenue, amounting to US$16,020.00m in 2024.
  • In Mongolia, the market for orthopedic devices is experiencing steady growth due to an aging population and a rise in sports-related injuries.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in Mongolia is experiencing steady growth, driven by customer preferences for advanced medical technology, increasing healthcare expenditure, and a growing aging population.

Customer preferences:
In line with global trends, customers in Mongolia are increasingly seeking advanced and innovative orthopedic devices that offer better functionality and improved patient outcomes. This includes a preference for minimally invasive surgical procedures and the use of implants and prosthetics that are more durable and have a longer lifespan. Additionally, customers are also looking for orthopedic devices that are customizable and can be tailored to their specific needs.

Trends in the market:
One of the key trends in the Orthopedic Devices market in Mongolia is the rising demand for joint replacement surgeries. This can be attributed to the growing aging population, as well as an increase in lifestyle diseases such as obesity and arthritis. As a result, there is a higher need for orthopedic devices such as hip and knee implants. The market is also witnessing an increase in the adoption of robotic-assisted surgeries, which offer greater precision and accuracy during procedures. Another trend in the market is the growing popularity of regenerative medicine and tissue engineering. This involves the use of stem cells, growth factors, and biomaterials to repair and regenerate damaged tissues and organs. The development of such technologies is expected to revolutionize the field of orthopedics, providing more effective treatment options for patients.

Local special circumstances:
Mongolia has a unique set of circumstances that impact the Orthopedic Devices market. The country has a relatively small population and a vast geographic area, which presents challenges in terms of healthcare accessibility and distribution of medical devices. The majority of the population resides in urban areas, which have better access to healthcare facilities. However, there is a need to improve healthcare infrastructure and services in rural areas to ensure equitable access to orthopedic devices.

Underlying macroeconomic factors:
The growth of the Orthopedic Devices market in Mongolia is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in healthcare expenditure. This has allowed for greater investment in healthcare infrastructure and the procurement of advanced medical devices. Additionally, the government has implemented healthcare reforms to improve the quality and accessibility of healthcare services, further driving the demand for orthopedic devices. In conclusion, the Orthopedic Devices market in Mongolia is growing due to customer preferences for advanced medical technology, increasing healthcare expenditure, and a growing aging population. The market is witnessing trends such as the rising demand for joint replacement surgeries and the adoption of regenerative medicine. However, the market is also influenced by local special circumstances, such as the need to improve healthcare accessibility in rural areas. Overall, the market is expected to continue its growth trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)